Investigating novel therapeutic targets and molecular mechanisms to treat botulinum neurotoxin A intoxication.

about

High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors Sensing the deadliest toxin: technologies for botulinum neurotoxin detection.

P2860

Q34987358-5CDA1B35-CD49-48A5-98E7-22DB5D77A4C7 Q35506757-BCFB6181-60C1-42EA-B02C-E8DCB6413A55

P2860

Investigating novel therapeutic targets and molecular mechanisms to treat botulinum neurotoxin A intoxication.

Item

http://www.wikidata.org/entity/Q40149882

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Investigating novel therapeuti ...... num neurotoxin A intoxication.

@en

type

Item

label

Investigating novel therapeuti ...... num neurotoxin A intoxication.

@en

prefLabel

Investigating novel therapeuti ...... num neurotoxin A intoxication.

@en

P1476

Investigating novel therapeuti ...... num neurotoxin A intoxication.

@en

P2093

Lisa M Eubanks

http://www.w3.org/2001/XMLSchema#string

Tobin J Dickerson

http://www.w3.org/2001/XMLSchema#string

P2860

Botulinal neurotoxins: revival of an old killer

Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility

The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.

Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors.

Computer-aided lead optimization: improved small-molecule inhibitor of the zinc endopeptidase of botulinum neurotoxin serotype A

Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins.

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons.

Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.

P304

677-687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17460913.2.6.677

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18041908

http://www.w3.org/2001/XMLSchema#string

P921

intoxication

Investigating novel therapeutic targets and molecular mechanisms to treat botulinum neurotoxin A intoxication.

about

P2860

P2860

Investigating novel therapeutic targets and molecular mechanisms to treat botulinum neurotoxin A intoxication.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921